Apolipoprotein E Induces Antiinflammatory Phenotype in Macrophages
Overview
Authors
Affiliations
Objective: Apolipoprotein E (apoE) exerts potent antiinflammatory effects. Here, we investigated the effect of apoE on the functional phenotype of macrophages.
Methods And Results: Human apoE receptors very-low-density lipoprotein receptor (VLDL-R) and apoE receptor-2 (apoER2) were stably expressed in RAW264.7 mouse macrophages. In these cells, apoE downregulated markers of the proinflammatory M1 phenotype (inducible nitric oxide synthase, interleukin [IL]-12, macrophage inflammatory protein-1α) but upregulated markers of the antiinflammatory M2 phenotype (arginase I, SOCS3, IL-1 receptor antagonist [IL-1RA]). In addition, M1 macrophage responses (migration, generation of reactive oxygen species, antibody-dependent cell cytotoxicity, phagocytosis), as well as poly(I:C)- or interferon-γ-induced production of proinflammatory cytokines; cyclooxygenase-2 expression; and activation of nuclear factor-κB, IκB, and STAT1, were suppressed in VLDL-R- or apoER2-expressing cells. Conversely, the suppression of the M2 phenotype and the enhanced response to poly(I:C) were observed in apoE-producing bone marrow macrophages derived from VLDL-R-deficient mice but not wild-type or low-density lipoprotein receptor-deficient mice. The modulatory effects of apoE on macrophage polarization were inhibited in apoE receptor-expressing RAW264.7 cells exposed to SB220025, a p38 mitogen-activated protein kinase inhibitor, and PP1, a tyrosine kinase inhibitor. Accordingly, apoE induced tyrosine kinase-dependent activation of p38 mitogen-activated protein kinase in VLDL-R- or apoER2-expressing macrophages. Under in vivo conditions, apoE-/- mice transplanted with apoE-producing wild-type bone marrow showed increased plasma IL-1RA levels, and peritoneal macrophages of transplanted animals were shifted to the M2 phenotype (increased IL-1RA production and CD206 expression).
Conclusions: ApoE signaling via VLDL-R or apoER2 promotes macrophage conversion from the proinflammatory M1 to the antiinflammatory M2 phenotype. This effect may represent a novel antiinflammatory activity of apoE.
Avila G, Bonnet M, Viala D, Dejean S, Agazzi A, Lecchi C Sci Rep. 2025; 15(1):8069.
PMID: 40055486 PMC: 11889182. DOI: 10.1038/s41598-025-92550-3.
Metabolic Dysfunction-Associated Steatotic Liver Disease: Pathogenetic Links to Cardiovascular Risk.
Ionescu V, Gheorghe G, Bacalbasa N, Diaconu C Biomolecules. 2025; 15(2).
PMID: 40001466 PMC: 11852489. DOI: 10.3390/biom15020163.
Apolipoprotein E: A Potential Prognostic and Diagnostic Biomarker for Hepatocellular Carcinoma.
Li Y, Lu R, Abuduhailili X, Feng Y J Hepatocell Carcinoma. 2025; 12:301-324.
PMID: 39991517 PMC: 11844312. DOI: 10.2147/JHC.S504078.
Zhang H, Dai J, Mu Q, Zhao X, Lin Z, Wang K Front Immunol. 2025; 15():1491872.
PMID: 39850883 PMC: 11754191. DOI: 10.3389/fimmu.2024.1491872.
Turkson V, Haller A, Jaeschke A, Hui D Arterioscler Thromb Vasc Biol. 2024; 45(1):37-48.
PMID: 39508104 PMC: 11668615. DOI: 10.1161/ATVBAHA.124.321748.